A Study of Herceptin (Trastuzumab) Combination Therapy in Patients With Metastatic Urothelial Cancer

Clinical trial NCT02006667 · COMPLETED

Trial details

NCT number: NCT02006667
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Urinary Tract Cancer

Start date: 2001-01-01
Primary completion: 2010-01-01
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.